BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34329771)

  • 1. Targeted microbiome-sparing antibiotics.
    Avis T; Wilson FX; Khan N; Mason CS; Powell DJ
    Drug Discov Today; 2021 Sep; 26(9):2198-2203. PubMed ID: 34329771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotics as both friends and foes of the human gut microbiome: The microbial community approach.
    Nogueira T; David PHC; Pothier J
    Drug Dev Res; 2019 Feb; 80(1):86-97. PubMed ID: 30370682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotics, pediatric dysbiosis, and disease.
    Vangay P; Ward T; Gerber JS; Knights D
    Cell Host Microbe; 2015 May; 17(5):553-64. PubMed ID: 25974298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Antibiotic Treatment on Gut Microbiota and How to Overcome Its Negative Impacts on Human Health.
    Ribeiro CFA; Silveira GGOS; Cândido ES; Cardoso MH; Espínola Carvalho CM; Franco OL
    ACS Infect Dis; 2020 Oct; 6(10):2544-2559. PubMed ID: 32786282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
    Vemuri RC; Gundamaraju R; Shinde T; Eri R
    Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial monoclonal antibodies: the next generation?
    DiGiandomenico A; Sellman BR
    Curr Opin Microbiol; 2015 Oct; 27():78-85. PubMed ID: 26302478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation.
    Langdon A; Crook N; Dantas G
    Genome Med; 2016 Apr; 8(1):39. PubMed ID: 27074706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Check Time: Antibiotic Delivery Strategies to Reduce Antimicrobial Resistance.
    Kelly SA; Rodgers AM; O'Brien SC; Donnelly RF; Gilmore BF
    Trends Biotechnol; 2020 Apr; 38(4):447-462. PubMed ID: 31757410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Same Exposure but Two Radically Different Responses to Antibiotics: Resilience of the Salivary Microbiome versus Long-Term Microbial Shifts in Feces.
    Zaura E; Brandt BW; Teixeira de Mattos MJ; Buijs MJ; Caspers MP; Rashid MU; Weintraub A; Nord CE; Savell A; Hu Y; Coates AR; Hubank M; Spratt DA; Wilson M; Keijser BJ; Crielaard W
    mBio; 2015 Nov; 6(6):e01693-15. PubMed ID: 26556275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Pathogen-Selective Antibiotic Minimizes Disturbance to the Microbiome.
    Yao J; Carter RA; Vuagniaux G; Barbier M; Rosch JW; Rock CO
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4264-73. PubMed ID: 27161626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbial Interactions and Interventions in Colorectal Cancer.
    Van Raay T; Allen-Vercoe E
    Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28643625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the human gut microbiota in colonization and infection with multidrug-resistant bacteria.
    Wuethrich I; W Pelzer B; Khodamoradi Y; Vehreschild MJGT
    Gut Microbes; 2021; 13(1):1-13. PubMed ID: 33870869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotics and the Human Microbiome: A Survey of Prescribing Clinicians' Knowledge and Opinions Regarding the Link between Antibiotic-Induced Dysbiosis and Immune-Mediated Disease.
    Wilson M; Mello MJ; Gruppuso PA
    R I Med J (2013); 2021 Sep; 104(7):59-63. PubMed ID: 34437668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse consequences of neonatal antibiotic exposure.
    Cotten CM
    Curr Opin Pediatr; 2016 Apr; 28(2):141-9. PubMed ID: 26886785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rebalancing the Caries Microbiome Dysbiosis: Targeted Treatment and Sugar Alcohols.
    Zhan L
    Adv Dent Res; 2018 Feb; 29(1):110-116. PubMed ID: 29355418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of fluoroquinolones on human microbiota. Focus on the emergence of antibiotic resistance.
    de Lastours V; Fantin B
    Future Microbiol; 2015; 10(7):1241-55. PubMed ID: 26119580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Validation of a Novel Microbiome-Based Biomarker of Post-antibiotic Dysbiosis and Subsequent Restoration.
    Blount K; Jones C; Walsh D; Gonzalez C; Shannon WD
    Front Microbiol; 2021; 12():781275. PubMed ID: 35058900
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibiotic-Driven Dysbiosis Mediates Intraluminal Agglutination and Alternative Segregation of Enterococcus faecium from the Intestinal Epithelium.
    Hendrickx AP; Top J; Bayjanov JR; Kemperman H; Rogers MR; Paganelli FL; Bonten MJ; Willems RJ
    mBio; 2015 Nov; 6(6):e01346-15. PubMed ID: 26556272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defeating Antibiotic-Resistant Bacteria: Exploring Alternative Therapies for a Post-Antibiotic Era.
    Wang CH; Hsieh YH; Powers ZM; Kao CY
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bacterial sepsis : Diagnostics and calculated antibiotic therapy].
    Richter DC; Heininger A; Brenner T; Hochreiter M; Bernhard M; Briegel J; Dubler S; Grabein B; Hecker A; Krüger WA; Mayer K; Pletz MW; Störzinger D; Pinder N; Hoppe-Tichy T; Weiterer S; Zimmermann S; Brinkmann A; Weigand MA; Lichtenstern C
    Anaesthesist; 2017 Oct; 66(10):737-761. PubMed ID: 28980026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.